Cohbar, inc. (CWBR)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities:
Net loss

-14,341

-13,044

-13,518

-14,781

-15,039

-15,705

-14,349

-12,597

-11,187

-9,833

-8,676

-7,469

-7,090

-6,074

-5,548

-4,973

-4,313

-3,878

-3,223

-2,551

-2,346

-1,819

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

157

147

132

115

96

79

61

58

58

57

66

65

61

57

53

48

42

30

19

9

2

2

0

0

0

Stock-based compensation

2,728

2,609

2,930

3,959

4,103

4,318

3,853

2,807

2,197

1,633

1,392

1,015

1,026

735

610

513

374

396

375

298

450

305

0

0

0

Equity modification expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount

402

420

420

420

414

311

206

100

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Amortization of debt issuance costs

18

19

19

19

18

14

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Discount on investments

-

34

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

-4

-40

-95

-122

0

0

0

Prepaid expenses and other current assets

86

100

245

236

-206

96

125

133

246

53

31

36

48

22

-18

31

40

68

70

70

65

4

0

0

0

Accounts payable

206

-697

157

-573

-183

650

-355

10

54

388

151

504

83

-106

267

28

136

-80

59

67

68

235

0

0

0

Accrued liabilities

440

564

317

221

198

102

161

244

110

116

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-149

-105

20

128

235

0

0

0

Accrued payroll and other compensation

29

10

-17

-417

10

164

34

546

350

55

-90

-68

59

230

57

149

48

113

137

54

54

84

0

0

0

Net cash used in operating activities

-9,686

-10,106

-9,760

-11,245

-10,134

-10,130

0

0

0

-

-

-

-

-

-

-

-3,877

-

0

0

0

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

0

0

Cash flows from investing activities:
Purchases of property and equipment

152

149

0

0

0

-

-

-

-

-

-

-

-

88

72

48

221

225

222

215

14

2

0

0

0

Patent costs

-

-

-

-

-

1

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Payment for security deposit

0

-

-

-

-

-

-

-

-

-

-

-

-

16

6

9

6

19

19

16

15

0

0

0

0

Purchases of investments

-

40,348

56,876

53,263

55,388

41,402

29,580

27,799

17,586

21,414

22,138

16,187

15,412

14,093

12,152

13,072

13,492

12,731

0

0

0

-

-

-

-

Proceeds from redemptions of investments

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from redemptions of investments

-

-

-

-

-

-30,541

-22,088

-17,332

-22,413

-21,214

-16,188

-16,512

-13,843

-14,152

-15,821

-14,395

-11,986

-7,244

0

0

0

-

-

-

-

Net cash (used in) provided by investing activities

15,322

16,338

1,718

78

-14,421

-11,292

0

0

0

-

-

-

-

-

-

-

-1,734

-

0

0

0

-

-

-

-

Investments in marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

0

0

Cash flows from financing activities:
Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35

538

756

764

749

0

0

0

Proceeds from convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

210

0

0

0

Debt issuance costs

-

-

-

-

-

57

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from the Controlled Equity Offering, net

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

10,253

10,253

10,253

10,253

0

0

0

0

Proceeds from exercise of warrants

-

57

57

143

147

678

760

674

671

2,487

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

Repayment of note payable

-

-

-

-

-

-

-

-

-

205

205

102

102

0

0

0

0

-

-

-

-

-

-

-

-

Proceeds from private offering, net

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

2,700

2,700

2,700

2,700

0

0

0

0

Proceeds from exercise of compensation options

-

-

-

-

-

-

-

-

-

-

-

-

-

731

731

496

6

55

0

0

0

-

-

-

-

Proceeds from exercise of employee stock options

442

552

321

379

500

494

555

498

255

129

19

19

19

2

2

2

2

0

0

0

0

-

0

0

0

Net cash provided by financing activities

442

609

379

522

21,685

24,321

0

0

0

-

-

-

-

-

-

-

3

-

0

0

0

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

0

0

Net decrease in cash and cash equivalents

6,078

6,841

-7,662

-10,644

-2,870

2,898

6,374

9,824

4,093

-434

-3,697

-996

-1,476

-1,546

512

-1,763

-5,608

3,609

3,680

5,243

9,810

1,049

0

0

0

Non-cash investing and financing activities:
Warrants issued in connection with note payable

-

-

-

-

-

1,253

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Warrants issued in connection with bridge loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Reclassification of deferred offering costs to equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

785

785

785

785

0

0

0

0

Conversion of Series B Preferred Stock to Common Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

5,400

5,400

5

0

0

0

0

Supplemental disclosure of cash flow information:
Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

0

-

0

0

0

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

14

12

0

0

0

0

0

0

0

0

-

-

-

-